0001140361-17-007725.txt : 20170215
0001140361-17-007725.hdr.sgml : 20170215
20170215164143
ACCESSION NUMBER: 0001140361-17-007725
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170214
FILED AS OF DATE: 20170215
DATE AS OF CHANGE: 20170215
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BioRestorative Therapies, Inc.
CENTRAL INDEX KEY: 0001505497
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
IRS NUMBER: 911835664
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 40 MARCUS DRIVE
CITY: MELVILLE
STATE: NY
ZIP: 11747
BUSINESS PHONE: (631) 760-8100
MAIL ADDRESS:
STREET 1: 40 MARCUS DRIVE
CITY: MELVILLE
STATE: NY
ZIP: 11747
FORMER COMPANY:
FORMER CONFORMED NAME: Stem Cell Assurance, Inc.
DATE OF NAME CHANGE: 20101110
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Field Edward L.
CENTRAL INDEX KEY: 0001435185
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37603
FILM NUMBER: 17615141
MAIL ADDRESS:
STREET 1: C/O BIORESTORATIVE THERAPIES, INC.
STREET 2: 40 MARCUS DRIVE, SUITE 1
CITY: MELVILLE
STATE: NY
ZIP: 11747
4
1
doc1.xml
FORM 4
X0306
4
2017-02-14
0
0001505497
BioRestorative Therapies, Inc.
BRTX
0001435185
Field Edward L.
40 MARCUS DRIVE
MELVILLE
NY
11747
0
1
0
0
President brtxDISC Division
Option
9.20
2017-02-14
4
D
0
25000
D
2025-02-09
Common Stock
25000
0
D
Option
4.7
2017-02-14
4
A
0
25000
A
2025-02-09
Common Stock
25000
25000
D
Option
7
2017-02-14
4
D
0
25000
D
2025-09-04
Common Stock
25000
0
D
Option
4.7
2017-02-14
4
A
0
25000
A
2025-09-04
Common Stock
25000
25000
D
Option
3.73
2026-06-10
Common Stock
80000
80000
D
The option vests to the extent of 8,334 shares on February 9, 2016 and 8,333 shares on each of February 9, 2017 and February 9, 2018.
The option is exercisable to the extent of 8,334 shares on September 4, 2016 and 8,333 shares on each of September 4, 2017 and September 4, 2018.
The option is exercisable to the extent of 26,667 shares on each of June 10, 2017 and June 10, 2018, and 26,666 shares on June 10, 2019.
The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price.
/s/ Edward L. Field
2017-02-14